Heart Attack Medications are less likely to be offered to kidney patients
Kidney patients are less likely to get the suggested medications after undergoing heart attack, a new study suggests.
According to this report that will be published in the September issue of the Clinical Journal of the American Society of Nephrology demonstrates that dialysis are required to end-stage renal disease patients and they are not given heart-saving medicines like beta blockers and other cholesterol-lowering medicines.
“Kidney disease is considered an established risk factor for heart attack and other cardiovascular diseases and it also serves as an indicator for such events” stated Wolfgang C. Winkelmayer, of Brigham and Women’s Hospital, in Boston in a news release.






